The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value

Overview of attention for article published in Frontiers in Nutrition, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 29,457 followers.

RT @Brunorm84: The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in #NAFLD patients gains value @Fron…

06 May 2023

Reply Repost Favourite

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in #NAFLD patients gains value @FrontNutrition https://t.co/5uqSIRYabk

06 May 2023

Reply Repost Favourite

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in no... https://t.co/7NWPwW1yBj

21 Mar 2023

Reply Repost Favourite

New Research: The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value: Background The PNPLA3 p.I148M impact on fat accumulation can be modulated by… https://t.co/9yG

21 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.